Aardvark Therapeutics (AARD) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results Mar 24, 2026 07:36AM
Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD) Nov 14, 2025 07:08AM
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September Aug 27, 2025 04:10PM
Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD) Aug 21, 2025 08:00AM
Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD) Aug 14, 2025 07:24AM


Apr 1, 2025 07:11AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)
Feb 12, 2025 10:38PM Aardvark Therapeutics Announces Pricing of Initial Public Offering